RLYB (Rallybio Corp) Bozor qiymatining balans qiymatiga nisbati

rallybio.com (RLYB) kompaniyasining rasmiy ramzlari

Ushbu jadvalda Rallybio Corporation (RLYB) ning 0.93 da belgilangan bozor qiymati ko'rsatilgan. Kompaniyaning hozirgi holati davom etayotgan klinik sinovlar tufayli daromadning yetishmasligi bilan tavsiflanadi, bu esa uning narx belgilash qobiliyatini vaqtincha cheklaydi. Operatsion faoliyat yetim dorilarni tashish paytida qattiq harorat nazoratiga bog'liq. Asosiy salohiyat FNAITda homilani ona immunitetidan himoya qilishning noyob usulini ishlab chiqishga asoslangan.

RLYB rallybio.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 29.10.2026 oraligʻida

Rallybio Corporation (RLYB) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi rallybio.com|RLYB - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Rallybio Corp.|RLYB - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Rallybio|RLYB - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati rallybio.com|RLYB - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Rallybio Corporation|RLYB - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati rallybio.com|RLYB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Rallybio Corp.|RLYB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Rallybio
Kompaniyaning dastlabki tahlili:Rallybio Corp - RLYB
rallybio.com original mahsuloti

Bozor qiymatining buxgalteriya qiymatiga nisbati kompaniyaning bozor qiymatining uning sof aktivlaridan yuqoriligini o'lchaydi. Rallybio Corporation (RLYB) uchun ushbu ko'rsatkich homilador ayollar uchun profilaktika tibbiyoti sohasidagi R&D loyihalari muvaffaqiyatiga nisbatan investorlar kutganlarini aks ettiradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati tendentsiyasidagi 0.93 ning joriy qiymati intellektual kapitalning haddan tashqari yuqori baholanganlik darajasini ko'rsatadi. Grafikning yuqoriga yo'nalgan egri chizig'i bozorning inqilobiy antitelolarga bo'lgan ishonchini bildiradi, bozor narxining aktivlardan haddan tashqari chetlashishi esa korreksiya xatarlarini yuzaga keltiradi.

Asosiy raqobatchilar

Haleon plc (HLN) - Bozor kapitallashuvining balans qiymatiga nisbati|KVUE (kenvue.com) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ENTX (enterabio.com)|Bozor qiymatining balans qiymatiga nisbati MindWalk Holdings Inc.|Balans qiymatiga nisbatan bozor qiymati ABVC BioPharma Inc. ABVC|Cumberland Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|QNTM: Bozor kapitallashuvining balans qiymatiga nisbati|FibroGen, Inc. (FGEN) - Bozor qiymatining balans qiymatiga nisbati|TELO (telomirpharma.com) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Rani Therapeutics Holdings|Bozor qiymatining balans qiymatiga nisbati Synergy CHC Corporation (SNYR)|Lexaria Bioscience - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati Pheton Holdings PTHL|Bozor qiymatining balans qiymatiga nisbati Aptorum Group Ltd APM|Bozor kapitallashuvining balans qiymatiga nisbati LYRA (Lyra Therapeutics)|IBO: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati TNFA|Bozor qiymatining balans qiymatiga koeffitsiyenti cbdMD|PRFX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO (Lipella Pharmaceuticals, Inc.)|Kapitallashuvning sof aktivlarga nisbati OPTN (OptiNose Inc)|PIRS: Bozor qiymatining balans qiymatiga nisbati|Procaps Group Corp - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Petros Pharmaceuticals (PTPI)|QLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati ACELYRIN (SLRN)|TFFP (TFF Pharmaceuticals Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi